Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001781785 | SCV002018646 | pathogenic | not provided | 2022-07-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001781785 | SCV003762025 | pathogenic | not provided | 2023-01-23 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Based on the understanding of this genetic alteration, it may be amenable to nonsense read-through therapy that is currently available or in clinical trials for males; This variant is associated with the following publications: (PMID: 30342905) |